Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Vogt

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
MMW Fortschritte Der Medizin|June 15, 2023
[Statin intolerance - statin tolerance]Anja Vogt, Klaus G Parhofer
Expert Opinion on Pharmacotherapy|March 13, 2013
The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery diseaseAnja Vogt, Klaus G Parhofer
Journal of Agricultural and Food Chemistry|November 19, 2009
Isolation and identification of a new cysteine sulfoxide and volatile sulfur compounds from Allium subgenus MelanocrommyumJan Kusterer, Anja Vogt, Michael Keusgen
Vascular Health and Risk Management|November 1, 2007
Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS studyAnja Vogt, Ursula Kassner, Ulrike Hostalek, et al.
Journal of Agricultural and Food Chemistry|February 6, 2008
Isolation and identification of a red pigment from Allium subgenus MelanocrommyumJarmila Jedelská, Anja Vogt, Uwe Michael Reinscheid, et al.
Journal of Clinical Lipidology|April 9, 2016
Quality of life in patients treated with lipoprotein apheresisAdrian Rosada, Ursula Kassner, Dagmar Banisch, et al.
Atherosclerosis|August 30, 2018
Corrigendum to: "Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study)" [Atherosclerosis 259 (2017 Apr) 20-25]Elisa Waldmann, Anja Vogt, Alexander Crispin, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 8, 2025
Evaluation of phenotypic and behavioral toxicity of micro- and nano-plastic polystyrene particles in larval zebrafish (Danio rerio)Bailey Levesque, Sabahudin Hrapovic, Fabrice Berrué, et al.
Artificial Organs|July 30, 2013
Does regular lipid apheresis in patients with isolated elevated lipoprotein(a) levels reduce the incidence of cardiovascular events?Adrian Rosada, Ursula Kassner, Anja Vogt, et al.
Atherosclerosis|March 11, 2017
Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study)Elisa Waldmann, Anja Vogt, Alexander Crispin, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
MMW Fortschritte Der Medizin|June 15, 2023
[Statin intolerance - statin tolerance]Anja Vogt, Klaus G Parhofer
Expert Opinion on Pharmacotherapy|March 13, 2013
The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery diseaseAnja Vogt, Klaus G Parhofer
Journal of Agricultural and Food Chemistry|November 19, 2009
Isolation and identification of a new cysteine sulfoxide and volatile sulfur compounds from Allium subgenus MelanocrommyumJan Kusterer, Anja Vogt, Michael Keusgen
Vascular Health and Risk Management|November 1, 2007
Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS studyAnja Vogt, Ursula Kassner, Ulrike Hostalek, et al.
Journal of Agricultural and Food Chemistry|February 6, 2008
Isolation and identification of a red pigment from Allium subgenus MelanocrommyumJarmila Jedelská, Anja Vogt, Uwe Michael Reinscheid, et al.
Journal of Clinical Lipidology|April 9, 2016
Quality of life in patients treated with lipoprotein apheresisAdrian Rosada, Ursula Kassner, Dagmar Banisch, et al.
Atherosclerosis|August 30, 2018
Corrigendum to: "Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study)" [Atherosclerosis 259 (2017 Apr) 20-25]Elisa Waldmann, Anja Vogt, Alexander Crispin, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 8, 2025
Evaluation of phenotypic and behavioral toxicity of micro- and nano-plastic polystyrene particles in larval zebrafish (Danio rerio)Bailey Levesque, Sabahudin Hrapovic, Fabrice Berrué, et al.
Artificial Organs|July 30, 2013
Does regular lipid apheresis in patients with isolated elevated lipoprotein(a) levels reduce the incidence of cardiovascular events?Adrian Rosada, Ursula Kassner, Anja Vogt, et al.
Atherosclerosis|March 11, 2017
Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study)Elisa Waldmann, Anja Vogt, Alexander Crispin, et al.
Pageof 6